Global Kinetics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Melbourne, VIC Australia
Total Funding:$20.5M
Industry:Medical Equip
Founded:2007
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Global Kinetics's estimated annual revenue is currently $14.3M per year.
  • Global Kinetics's estimated revenue per employee is $251,000
  • Global Kinetics's total funding is $20.5M.

Employee Data

  • Global Kinetics has 57 Employees.
  • Global Kinetics grew their employee count by 14% last year.
  • Global Kinetics currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$14.3M5714%N/A-N/A
#2
$37.7M150N/AN/A-N/A
#3
$37.1M148N/AN/A-N/A
#4
$13.3M536%N/A-N/A
#5
$24.1M9625%N/A-N/A
#6
$19.6M7816%N/A-N/A
#7
$51M203N/AN/A-N/A
#8
$59M235N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

Global Kinetics Corporation (GKC) is committed to improving the lives of those with Parkinson's disease and other movement disorders, with advanced medical technologies. GKC is on a trajectory to revolutionize the management of Parkinson's disease by enabling informed treatment decisions which are based on continuous and objective measurement of patients key movement symptoms in everyday environments. Its lead product, the Parkinson's KinetiGraph (PKG), has been developed by neurologists at the world-renowned Florey Institute of Neuroscience in Melbourne, Australia. The PKG enables the precise monitoring, quantification and reporting of movement patterns of neurological diseases including bradykinesia, dyskinesia, tremor and immobility. Our PKG technology: Technically de-risked and established in market - over 3,000,000 hours of continuous Parkinson's monitoring delivered to date, representing more than 25,000 patient PKGs Changes clinical decisions more than 50% of the time Boasts significant key opinion leader support Is underpinned by robust clinical validation and regulatory clearance through FDA 510(k) in the USA, CE mark in Europe, TGA Class IIA ARTG 236583 listed The PKG system is being used in clinics across the U.S., Europe and Asia Pacific, enabling better clinical outcomes and reducing health care costs across the Parkinson's disease continuum. GKC continues to pursue partnerships with major pharmaceutical and medical technology companies to help measure efficacy of new and advanced therapies for one of the world's most widespread movement disorders. For further information, please visit our website, www.globalkineticscorporation.com

keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

57

Number of Employees

$14.3M

Revenue (est)

1

Current Jobs

14%

Employee Growth %

$20.5M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Global Kinetics News

09/03/2019 - Data Published in Functional Neurology Demonstrate that Global Kinetics' Personal KinetiGraph® (PKG®) is Uniquely Positioned to Enable Objective Assessment of Motor Fluctuations in Parkinson's

Data Published in Functional Neurology Demonstrate that Global Kinetics' Personal KinetiGraph® (PKG®) is Uniquely Positioned to Enable ...

05/07/2019 - Global Kinetics Corporation's PKG® Provides Clinically ...

Global Kinetics Corporation's PKG® Provides Clinically Meaningful Improvement in Symptom Assessment, Management, Medication ...

09/03/2019 - FIGUR8 launches body movement tracking platform ...

Additionally, in April wrist-worn Parkinson's disease monitors developed by Melbourne, Australia-based Global Kinetics Corporations were ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$14.5M5727%N/A-N/A
#2
$14.5M5727%N/A-N/A
#3
N/A5721%N/A-N/A
#4
N/A57104%N/A-N/A
#5
$14.7M589%N/A-N/A